Literature DB >> 29551001

Persistence of an iatrogenic atrial septal defect after a second-generation cryoballoon ablation of atrial fibrillation.

Tomonori Watanabe1, Shinsuke Miyazaki2, Takatsugu Kajiyama2, Sadamitsu Ichijo2, Takamitsu Takagi2, Miyako Igarashi2, Hiroaki Nakamura2, Hiroshi Taniguchi2, Hitoshi Hachiya2, Yoshito Iesaka2.   

Abstract

Persistent iatrogenic atrial septal defects (iASDs) can be observed after intervention requiring a left atria (LA) access, including pulmonary vein isolation (PVI) of atrial fibrillation (AF). We investigated the incidence of iASDs post-second-generation cryoballoon ablation and the pre-procedural predictors. Eighty-three paroxysmal AF patients underwent PVI using second-generation cryoballoons. The LA was accessed with single 15-Fr steerable sheaths following a radiofrequency transseptal puncture, and the iASD was evaluated with transthoracic echocardiography (TTE), a median of 9.3 (7.1-13.3) months post-procedure. All patients underwent pre-procedural contrast-enhanced multi-detector computed tomography (CT) to evaluate the LA and PV anatomy. iASDs were detected by TTE in 7 (8.4%) patients, a median of 15.5 (6.8-17.3) months post-procedure. Patients with iASDs had significantly larger LA volumes and smaller atrial septal angles, defined as the angle between the atrial septum and sagittal line on the horizontal section at the height of the fossa ovalis, which could be the transseptal puncture site measured on CT, and more likely hypertension than those without. Multivariate analyses revealed that the atrial septal angle was the sole predictor of iASDs [odds ratio 0.764, 95% confidence interval (CI) 0.624-0.935, p = 0.009], and the optimal cut-off value was 57.5° (sensitivity 85.7%, specificity 88.2%, 95% CI 0.873-0.995, p < 0.0001). Patients with iASDs were asymptomatic and had no adverse clinical events during a 17.7 (14.4-25.8) month median follow-up. iASDs were still detectable in 8.4% of patients a median of 15.5 months after the second-generation CB ablation, and the atrial septal angle might aid in predicting persistent iASDs.

Entities:  

Keywords:  Atrial fibrillation; Cryoballoon ablation; Iatrogenic atrial septal defect; Pulmonary vein isolation; Transseptal puncture

Mesh:

Year:  2018        PMID: 29551001     DOI: 10.1007/s00380-018-1147-z

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  19 in total

1.  Persistence of atrial septal defect after cryoballoon ablation of atrial fibrillation.

Authors:  Edmond M Cronin; Patrick Collier; Oussama M Wazni; Brian P Griffin; Wael A Jaber; Walid I Saliba
Journal:  J Am Coll Cardiol       Date:  2013-07-31       Impact factor: 24.094

2.  Persistence of iatrogenic atrial septal defect after pulmonary vein isolation--an underestimated risk?

Authors:  Christoph Hammerstingl; Lars Lickfett; Kyung-Mi Jeong; Clemens Troatz; Jan-Arne Wedekind; Klaus Tiemann; Berndt Lüderitz; Thorsten Lewalter
Journal:  Am Heart J       Date:  2006-08       Impact factor: 4.749

3.  Hemodynamically significant atrial septal defect after atrial fibrillation ablation: A hole to remember.

Authors:  Mian Atif Yousuf; Sulsal Haq; Robert E O'Donnell; Mehran Attari
Journal:  Heart Rhythm       Date:  2015-04-28       Impact factor: 6.343

4.  Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation.

Authors:  Raphaël P Martins; David Hamon; Olivier Césari; Albin Behaghel; Nathalie Behar; Jean-Marc Sellal; Jean-Claude Daubert; Philippe Mabo; Dominique Pavin
Journal:  Heart Rhythm       Date:  2014-01-01       Impact factor: 6.343

5.  Mid-to-long-term follow-up results of transcatheter closure of atrial septal defect in patients older than 40 years.

Authors:  Jou-Kou Wang; Shuenn-Nan Chiu; Ming-Tai Lin; Chun-An Chen; Chun-Wei Lu; Mei-Hwan Wu
Journal:  Heart Vessels       Date:  2016-08-16       Impact factor: 2.037

6.  The incidence and long-term clinical outcome of iatrogenic atrial septal defects secondary to transseptal catheterization with a 12F transseptal sheath.

Authors:  Sheldon M Singh; Pamela S Douglas; Vivek Y Reddy
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-01-19

7.  Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.

Authors:  Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

8.  Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation.

Authors:  Karl-Heinz Kuck; Josep Brugada; Alexander Fürnkranz; Andreas Metzner; Feifan Ouyang; K R Julian Chun; Arif Elvan; Thomas Arentz; Kurt Bestehorn; Stuart J Pocock; Jean-Paul Albenque; Claudio Tondo
Journal:  N Engl J Med       Date:  2016-04-04       Impact factor: 91.245

9.  Transcatheter closure of atrial septal defect protects from pulmonary edema: septal occluder device gradually reduces LR shunt.

Authors:  Tsutomu Murakami; Gaku Nakazawa; Hitomi Horinouchi; Sho Torii; Takeshi Ijichi; Yohei Ohno; Mari Amino; Norihiko Shinozaki; Nobuhiko Ogata; Fuminobu Yoshimachi; Koichiro Yoshioka; Yuji Ikari
Journal:  Heart Vessels       Date:  2016-06-17       Impact factor: 2.037

10.  Safety of fluoroscopy-guided transseptal approach for ablation of left-sided arrhythmias.

Authors:  Zviad Matoshvili; Hamid Bastani; Tara Bourke; Frieder Braunschweig; Nikola Drca; Kristjan Gudmundsson; Per Insulander; Anette Jemtrén; Göran Kennebäck; Ott Saluveer; Jonas Schwieler; Jari Tapanainen; Christer Wredlert; Mats Jensen-Urstad
Journal:  Europace       Date:  2017-12-01       Impact factor: 5.214

View more
  5 in total

1.  Treatment Complications of Atrial Fibrillation and Their Management.

Authors:  Allan Mattia; Joshua Newman; Frank Manetta
Journal:  Int J Angiol       Date:  2020-03-05

2.  Prospective evaluation of iatrogenic atrial septal defect after cryoballoon or radiofrequency catheter ablation of atrial fibrillation-"EVITA" study.

Authors:  Zsofia Nagy; Zsuzsanna Kis; Tamás Géczy; Andras Temesvari; Zoltan Som; Sarolta Borbas; Tamás Breuer; David Molnar; Csaba Foldesi; Attila Kardos
Journal:  J Interv Card Electrophysiol       Date:  2019-08-09       Impact factor: 1.900

3.  Heart failure caused by iatrogenic atrial septal defect after cryoballoon ablation for atrial fibrillation.

Authors:  Yasunobu Yamagishi; Yasushi Oginosawa; Kan Kikuchi; Jun Muneuchi; Keishiro Yagyu; Taro Miyamoto; Keita Tsukahara; Hisaharu Ohe; Ritsuko Kohno; Haruhiko Abe
Journal:  J Cardiol Cases       Date:  2021-07-07

4.  Evasion maneuver for transseptal approach during cryoballoon pulmonary vein isolation.

Authors:  Christian Blockhaus; Hans-Peter Waibler; Jan-Erik Gülker; Heinrich Klues; Alexander Bufe; Dong-In Shin
Journal:  J Saudi Heart Assoc       Date:  2018-06-01

5.  Hemodynamically significant iatrogenic atrial septal defects after cryoballoon ablation.

Authors:  Jayasheel Eshcol; Alan P Wimmer
Journal:  HeartRhythm Case Rep       Date:  2018-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.